IDIX Related Analyst PT Change
-
Wedbush Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Neutral
-
Maxim Group Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold
-
UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)
-
Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
-
Brean Murray Carret & Co. Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Hold; IDX184 on Clinical Hold Again
-
Wedbush Raises Price Target on Idenix Pharmaceuticals (IDIX) Following Pipeline Update
Back to IDIX Stock Lookup
